297 related articles for article (PubMed ID: 37402856)
1. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axis.
Hashimoto K
Mol Psychiatry; 2023 Dec; 28(12):4968-4976. PubMed ID: 37402856
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
3. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation.
Gold JE; Okyay RA; Licht WE; Hurley DJ
Pathogens; 2021 Jun; 10(6):. PubMed ID: 34204243
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
7. Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
Hu J; Zhang L; Lin W; Tang W; Chan FKL; Ng SC
Trends Food Sci Technol; 2021 Feb; 108():187-196. PubMed ID: 33519087
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support.
Giovanetti M; Pannella G; Altomare A; Rocchi G; Guarino M; Ciccozzi M; Riva E; Gherardi G
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543736
[TBL] [Abstract][Full Text] [Related]
9. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.
Vojdani A; Vojdani E; Saidara E; Maes M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851614
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
11. Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants.
Wang C; Ramasamy A; Verduzco-Gutierrez M; Brode WM; Melamed E
Virol J; 2023 Jun; 20(1):124. PubMed ID: 37328773
[TBL] [Abstract][Full Text] [Related]
12. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
[TBL] [Abstract][Full Text] [Related]
13. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang Y; Wu G; Zhao L; Wang W
mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
15. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
Xiang Z; Koo H; Chen Q; Zhou X; Liu Y; Simon-Soro A
J Oral Microbiol; 2020 Nov; 13(1):1853451. PubMed ID: 33312449
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients.
Blumenthal MJ; Lambarey H; Chetram A; Riou C; Wilkinson RJ; Schäfer G
Front Microbiol; 2021; 12():795555. PubMed ID: 35069495
[TBL] [Abstract][Full Text] [Related]
17. Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics.
Wais T; Hasan M; Rai V; Agrawal DK
Expert Rev Clin Immunol; 2022 Sep; 18(9):947-960. PubMed ID: 35868344
[TBL] [Abstract][Full Text] [Related]
18. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature.
Vakili K; Fathi M; Yaghoobpoor S; Sayehmiri F; Nazerian Y; Nazerian A; Mohamadkhani A; Khodabakhsh P; Réus GZ; Hajibeygi R; Rezaei-Tavirani M
Front Cell Infect Microbiol; 2022; 12():983089. PubMed ID: 36619768
[TBL] [Abstract][Full Text] [Related]
19. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
